The global demand for Compounded Bioidentical Hormone Therapy Market is presumed to reach the market size of nearly USD 675.44 MN by 2028 from USD 443.32 MN in 2021 with a CAGR of 6.3% under the study period 2022 - 2028.
Compounded ""bioidentical"" hormone therapy (cBHT), especially oestrogen and progesterone, is considered a safe and effective therapy for relieving menopause symptoms. Bioidentical hormones are synthetic hormones and are chemically identical to those produced by the human body. Bioidentical hormones operate as the body's hormones with relatively minor adverse effects because they are chemically comparable to the hormones produced by the body.
Market Dynamics
The rising geriatric population is one of the primary contributors projected to fuel the development and demand for compounded bioidentical hormone therapy. Furthermore, the global compounded bioidentical hormones therapy market is projected to expand due to increased screening for hormonal insufficiency and proliferation of the patient pool. Additionally, consumer awareness of compounded bioidentical hormone therapy and an increase in the occurrence of hormonal imbalance disorders are anticipated to push market expansion. Moreover, rising pharmaceutical use and healthcare spending are significant contributors to compounded bioidentical hormone therapy market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of compounded bioidentical hormone therapy. The growth and trends of compounded bioidentical hormone therapy industry provide a holistic approach to this study.
Market Segmentation
This section of the compounded bioidentical hormone therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Oestrogen
- Progesterone
- Testosterone
By Route Of Administration
- Oral
- Sublingual
- Percutaneous
- Implants
- Injectable
- Suppositories
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Compounded Bioidentical Hormone Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Compounded Bioidentical Hormone Therapy Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the compounded bioidentical hormone therapy market include SottoPelle, BioTE Medical, Advantage Pharmaceuticals Inc., Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Bio station, Noven Pharmaceuticals, Novartis AG, Pfizer Inc., Therapeutics MD Inc, Bayer AG, Novo Nordisk A/S. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.